Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Thyroid and hepatic function after high-dose ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy for neuroblastoma.

Autor: Quach, Alekist, Ji, Lingyun, Mishra, Vikash, Sznewajs, Aimee, Veatch, Janet, Huberty, John, Franc, Benjamin, Sposto, Richard, Groshen, Susan, Wei, Denice, Fitzgerald, Paul, Maris, John M., Yanik, Gregory, Hawkins, Randall A., Villablanca, Judith G., Matthay, Katherine K.

Publikováno v: Pediatric Blood & Cancer; Feb2011, Vol. 56 Issue 2, p191-201, 11p

Correlation of Tumor and Whole-Body Dosimetry with Tumor Response and Toxicity in Refractory Neuroblastoma Treated with ¹³¹I-MIBG.

Autor: Matthay, Katherine K., Panina, Colleen, Huberty, John, Price, David, Glidden, David V., Tang, H. Roger, Hawkins, Randall A., Veatch, Janet, Hasegawa, Bruce

Publikováno v: Journal of Nuclear Medicine; Nov2001, Vol. 42 Issue 11, p1713-1721, 9p, 4 Charts, 3 Graphs

Providing Bereavement Follow-up Through a Weekend Family Retreat.

Autor: Kramer, Robin F., Veatch, Janet, Abramovitz, Linda, Seeger, Rod, Senner, Anne

Publikováno v: Journal of Pediatric Oncology Nursing; Apr1997, Vol. 14 Issue 2, p129-130, 2p

Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.

Autor: Matthay KK; Department of Pediatrics, University of California, San Francisco, School of Medicine, and UCSF Children's Hospital, San Francisco, CA 94143-0106, USA. matthayk@peds.ucsf.edu, Tan JC, Villablanca JG, Yanik GA, Veatch J, Franc B, Twomey E, Horn B, Reynolds CP, Groshen S, Seeger RC, Maris JM

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2006 Jan 20; Vol. 24 (3), pp. 500-6.